RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-5562
Malaria parasiteP. berghei
Genotype
TaggedGene model (rodent): PBANKA_0829400; Gene model (P.falciparum): PF3D7_0928600; Gene product: conserved Plasmodium protein, unknown function
Name tag: 3xcMyc
Phenotype Asexual bloodstage;
Last modified: 18 October 2024, 11:54
  *RMgm-5562
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene tagging
Reference (PubMed-PMID number) Not published (yet)
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone RMgm-5555
Other information parent lineThis mutant (RMgm-5555) expresses (a flag-tagged) CAS9 (spCAS9) under control of the strong and constitutive hsp70 promoter. The mutant does not contain a drug-selectable marker.
The mutant parasite was generated by
Name PI/ResearcherJonsdottir TK, Bushell ESC
Name Group/DepartmentThe Laboratory for Molecular Infection Medicine Sweden
Name InstituteUmeå University
CityUmeå
CountrySweden
Name of the mutant parasite
RMgm numberRMgm-5562
Principal namePBANKA_0829400-3xcMyc
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationNo
Phenotype
Asexual blood stageThe mutant expresses a C-terminal 3x-cMyc-tagged version of PBANKA_0829400.
The 3x-cMyc tag was introduced into the 3’ of PBANKA_0829400 of the background line RMgm-5555. The Cas9 expressed from the genome in the PbCas9 background line (RMgm-5555) facilitated integration of the 3x-cMyc tag using the CRISPR-Cas9 P. berghei High-Throughput strategy (PbHiT). The pPbHiT vector contains the gRNA barcode, 100 bp homology arms and two guides per gene. The tagged-gene contains a 3'-UTR regions of hsp70 (PBANKA_0711900).
The expression of the protein was confirmed by Western blot analysis.
Gametocyte/GameteNot tested
Fertilization and ookineteNot tested
OocystNot tested
SporozoiteNot tested
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant expresses a C-terminal 3x-cMyc-tagged version of PBANKA_0829400.
The 3x-cMyc tag was introduced into the 3’ of PBANKA_0829400 of the background line RMgm-5555. The Cas9 expressed from the genome in the PbCas9 background line (RMgm-5555) facilitated integration of the 3x-cMyc tag using the CRISPR-Cas9 P. berghei High-Throughput strategy (PbHiT). The pPbHiT vector contains the gRNA barcode and 100 bp homology arms. The tagged-gene contains a 3'-UTR regions of hsp70 (PBANKA_0711900)

Published in: bioRxiv preprint doi: https://doi.org/10.1101/2024.04.20.590404

Protein (function)
-

Phenotype
The mutant expresses a C-terminal 3x-cMyc-tagged version of PBANKA_0829400.
The 3x-cMyc tag was introduced into the 3’ of PBANKA_0829400 of the background line RMgm-5555. The Cas9 expressed from the genome in the PbCas9 background line (RMgm-5555) facilitated integration of the 3x-cMyc tag using the CRISPR-Cas9 P. berghei High-Throughput strategy (PbHiT). The pPbHiT vector contains the gRNA barcode, 100 bp homology arms and two guides per gene. The tagged-gene contains a 3'-UTR regions of hsp70 (PBANKA_0711900).

Additional information
Using Cas9 to precisely engineer a double-strand break (DSB) enhances the efficiency of gene editing in Plasmodium when using a standard length (≤1000 bp) homology region (HR). Since Plasmodium lacks the pathway for canonical non-homologous end-joining (c-NHEJ), any CRISPR-Cas9 mediated edit requires a homology directed repair (HDR) template to facilitate DSB repair. This prohibits the adoption of standard CRISPR-Cas9 disruption screens that rely on c-NHEJ, which introduces insertion and deletion mutations during repair. The HDR template must instead be delivered into the parasite together with the corresponding guide RNA (gRNA) and can be supplied in the same genetic vector that carries the gRNA or on a separate linear or circular DNA molecule. The development of CRISPR-Cas9 screens in Plasmodium requires a scalable system where the gRNA and the HR are physically linked to ensure that each parasite receives a matched gRNA and HR during pooled transfections. Recently, the development of a T. gondii high-throughput tagging CRISPR-Cas9 system, which physically couples the gRNA and HR in a single scalable vector, has paved the way for HDR-mediated CRISPR-Cas9 screens. We have developed a scalable CRISPR system called PbHiT for the rodent malaria parasite P. berghei, which uses a single cloning step to generate targeting vectors with 100 bp homology arms physically linked to a guide RNA (gRNA) that effectively integrate into the target locus.

To develop an improved P. berghei CRISPR-Cas9 editing system, we first modified the existing Plasmodium yoelii pYCm CRISPR-Cas9 vector by replacing the P. yoelii U6 promoter with the endogenous P. berghei U6 promoter to drive gRNA expression. The resulting vector, pPbU6-hdhfr/yfcu-Cas9, encodes Streptococcus pyogenes Cas9 (spCas9) together with the dual positive/negative selection marker human dihydrofolate reductase/yeast cytosine deaminase and uridyl phosphoribosyl transferase (hdhfr/yfcu).

Generation and evaluation of a vector lacking Cas9, pPbU6-hdhfr/yfcu in combination with the PbCas9 parasite line (RMgm-5555).
We introduced a 3xHA tag into the 3’ of rap2/3 (RMgm-5556). The Cas9 expressed from the genome in the new PbCas9 background line facilitated integration of the 3xHA tag using both the one-plasmid and PCR-template approaches (with ~500 bp homology arms). This one-plasmid approach was efficient, with mice reaching a parasitemia above 0.5%, six days post-transfection.

The pPbHiT vector containing the gRNA barcode and 100 bp homology arms efficiently integrates into the target locus
Scaling-up CRISPR-Cas9 in organisms lacking the c-NHEJ pathway requires the gene-specific gRNA and HR to be physically linked in the same plasmid to enable pooled transfections. Having established that the P. berghei genome can be effectively modified using short homology arms in a one-plasmid approach enabled us to adopt a high-throughput tagging strategy previously used in T. gondii. The CRISPR-Cas9 P. berghei High-Throughput strategy (PbHiT) developed here, relies on single-step cloning of a 320 bp synthetic fragment carrying the gRNA and homology arms into the pPbU6-hdhfr/yfcu-HiT (referred to as pPbHiT) vector, which we generated by modifying the pPbU6-hdhfr/yfcu vector. Before transfection into Cas9-expressing parasites, the final pPbHiT vector containing the synthetic fragment is linearised, resulting in the homology arm sequences that drive integration flanking the entire plasmid. To reduce the likelihood of unintegrated plasmids maintained as episomes, the linearised vector was gel extracted prior to transfection. When a Cas9-mediated DSB is repaired through HDR, the entire vector is inserted into the target locus and facilitates the editing of the target gene. The gene-specific gRNA is thereby stably integrated into the genome and serves as a molecular barcode to identify the edited parasites by NGS. The pPbHiT vector can be used for epitope tagging and gene knockout by adapting the position of the homology regions and gRNA. For epitope tagging, the endogenous 3’ untranslated region (UTR) of the target gene is replaced by the 3’UTR of the constitutively expressed gene hsp70.
To test this strategy, the pPbHiT vector containing a triple cMyc (3x-cMyc) epitope tag was used to evaluate the efficiency of tagging genes using 50 and 100 bp homology arms. We targeted both rap2/3 and PBANKA_1224200 (RMgm-5557), a gene predicted to be localised along the secretory pathway. 100 bp homology arms resulted in efficient editing for both targets. Furthermore, the wild type target loci were undetectable by PCR for both targets when using 100 bp homology arms. To further evaluate the performance of the PbHiT system, five other genes were tagged with 3x-cMyc: PBANKA_1225600 (RMgm-5558), PBANKA_0914500 (RMgm-5559), PBANKA_0622900 (RMgm-5560), PBANKA_1451000 (RMgm-5561), and PBANKA_0829400 (RMgm-5562) using 100 bp homology arms and two guides per gene. For PBANKA_0829400 we only obtained one gRNA within the accepted distance from the editing site, which is restricted to the 3’UTR for epitope tagging. Parasites emerged at different days post-transfection (days four to six), with a marked difference between the same gene targeted by the different gRNA, likely reflecting gRNA efficiency. However, this was not directly correlated to either the proximity of the guide to the editing site or the on/off gRNA target score. Genotyping PCRs confirmed the correct integration of the epitope tag in the 3’ UTR of the target gene. One gene (PBANKA_0914500) did not show any 3’ integration product when edited by guide one, however the 5’ integration was confirmed. The expression of all but two of the tagged proteins (PBANKA_1451000 and PBANKA_0829400) was confirmed by Western blot for guide one. PBANKA_0914500-cMyc was detectable by Western blot, despite that it did not show a positive 3’ integration band by PCR. We also confirmed by IFAs that RAP2/3 and PBANKA_0622900 are expressed in schizonts, in agreement with transcriptomic data. This shows that changing the gene’s 3’UTR does not affect mRNA stability and facilitates protein expression at the expected stage. In the case of RAP2/3, the 3x-cMyc tagged protein was observed in the apical end of the parasites, which is consistent with rhoptry localisation and demonstrates that the 3x-cMyc tag is not altering protein localisation. We also tested if transfections could be done without gel extracting the final pPbHiT linearised vector and saw no evidence of episomes by PCR.

PbHiT enables pooled vector transfections that recapitulate published knockout phenotypes
Having established the efficiency of the pPbHiT vector for editing single genes, we assessed the performance of the PbHiT system in pooled knockout vector transfections. We selected 12 target genes with in vivo blood-stage growth knockout phenotypes assigned with high confidence in the PlasmoGEM screen and classified as essential (n = 4), dispensable (n = 4), or slow growers (n = 4). Most genes were targeted by two gRNAs except for PBANKA_0515000 (ookinete surface protein P25, p25) and PBANKA_0933700 (mitogen-activated protein kinase 2, map2k), which had one guide each. A total of 22X knockout vectors were individually generated before pooling together in equal amounts, linearised, and transfected into the PbCas9 parasite line. Blood samples were taken at days four to eight post-transfection, genomic DNA was extracted and NGS sequencing libraries were prepared by nested PCR. Results revealed a high concordance between the PbHiT and PlasmoGEM data.

PbHiT facilitates pooled transfection CRISPR screens in P. berghei
We provide evidence of dispensability for four unstudied genes: PBANKA_0103700 (RMgm-5563), PBANKA_0812900 (RMgm-5564), PBANKA_0409000 (RMgm-5565), PBANKA_0821200 (RMgm-5566) that were reported non-mutable in the piggyBac screen but here we were able to knockout using PbHiT

Other mutants


  Tagged: Mutant parasite with a tagged gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0829400
Gene Model P. falciparum ortholog PF3D7_0928600
Gene productconserved Plasmodium protein, unknown function
Gene product: Alternative name
Details of the genetic modification
Name of the tag3xcMyc
Details of taggingC-terminal
Additional remarks: tagging
Commercial source of tag-antibodies
Type of plasmid/constructCRISPR/Cas9 construct: integration through double strand break repair
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr/yfcu
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationTo generate a CRISPR-Cas9 system specifically adapted for P. berghei we modified the P. yoelii pYCm and pYCs plasmids (kind gift from Jing Yuan) by changing the P. yoelii U6 promoter (PyU6) that drives gRNA expression, for the P. berghei U6 promoter (PbU6; PBANKA_1354380). To this end, the PbU6 sequence was amplified from P. berghei ANKA cl15cy1 genomic DNA and cloned into the pYCs and pYCm plasmids following digestion with KasI and StuI (NEB), using the NEBuilder HiFi DNA reaction master mix. The resultant vectors were named pPbU6-hdhfr/yfcu-Cas9 (addgene ID 216423, derived from pYCm and containing the coding sequence for spCas9 nuclease) and pPbU6-hdhfr/yfcu (Addgene #216422, derived from pYCs). Both vectors contain the dual selection marker hdhfr/yfcu for positive selection with pyrimethamine and negative selection using 5-fluorocytosine (5-FC).

To adapt this system for ease of cloning and pooled transfections, we generated a vector using the pPbU6-hdhfr/yfcu backbone in which the original gRNA scaffold sequence was replaced with a synthetic modular fragment carrying the following features: BsmBI/PstI/3x-cMyc/SalI/NotI/stop codon (TAG)/hsp70 3’UTR/AatII (ordered from GeneWiz-Azenta). The pPbU6-hdhfr/yfcu plasmid and the synthetic fragment were digested with BsmBI and AatII (NEB) and ligated into the vector with T4 ligase (NEB). The multiple cloning sites allow adding new or replacing all features. The resulting plasmid was named pPbU6-hdhfr/yfcu-HiT (Addgene #216421), referred to as pPbHiT.

Vectors to target specific genes using pPbU6-hdhfr/yfcu were generated by first cloning the gRNAs into BsmBI-digested vectors. To this end, two single-stranded oligonucleotides (Integrated DNA Technologies, IDT) were designed containing the guide sequence fused to a 4-nucleotide sequence (TATT for the forward guide and AAAC for the reverse guide) corresponding to the overhangs generated when digesting the vectors with BsmBI. Single-stranded oligonucleotides were mixed in a 1:1 ratio, phosphorylated using the T4 polynucleotide kinase enzyme (NEB), and annealed by incubating at 95 °C for 5 min followed by a temperature ramp of -5 °C every minute, until reaching 25 °C. A 1:200 dilution of the double-stranded gRNA was ligated into BsmBI-digested plasmids using T4 ligase (NEB). One μL of the ligated vector was then transformed into chemically competent XL Gold E. coli (Agilent Technologies). Integration was determined by colony PCR using the gRNA forward oligonucleotide and the generic primer gRNAseq_R. The HDR templates were synthesised by GeneWiz-Azenta. To generate tagging vectors, the homology arms were designed flanking the cut-site of the gRNA, which was placed in the 3’ end of the coding sequence. Furthermore, the area containing the gRNA target sequence was recodonised to avoid successive cutting of the edited locus, and the desired epitope tag was added to the repair template.
The HDR template was provided either in the same plasmid that carried the gRNA (one-plasmid approach), or as a PCR product (PCR-template approach). For the one-plasmid approach, the gene-specific homology repair template was ligated into plasmids carrying the corresponding gRNA using HindIII. For the PCR-template approach, the HDR template was amplified by PCR and the amplicon was incubated with DpnI or gel extracted. For rap2/3 only one guide was used per transfection but for sdg, piesp1 and mahrp1a two guides were mixed together with PCR-template prior to transfection and recodonised area in the HDR template covered the region of both gRNAs.

The pPbHiT vectors to either knock out or tag target genes were designed with 50 or 100 bp homology arms, and the gRNAs were located in the region between the two homology arms, which results in the removal of the target site after recombination has occurred. For pPbHiT tagging vectors, the 5’ homology arm (HR1) is located at the end of the coding sequence and comprises the region immediately upstream of the stop codon without including it, whereas the 3’ homology arm (HR2) starts after the Cas9 cut site, 6 bp downstream of the gRNA protospacer adjacent motif (PAM) site. Guides within 50 bp from the end of the coding sequence are prioritised for tagging vectors to maximise editing efficiency. For pPbHiT knockout vectors, the HR1 is located in the 5’ UTR of the target gene immediately before the ATG codon, and the HR2 is designed in the 3’ UTR of the target gene just after the stop codon. All gene-specific elements and the generic gRNA scaffold were synthesised as a single synthetic fragment (Genewiz-Azenta) according to the following structure: BbsI/gRNA/Scaffold/HR2/AvrII/HR1/PstI for cloning into pPbHiT.
If any of the cut sites were present in the sequence of the HR, the nucleotides were modified by introducing a silent mutation to remove the enzyme recognition site. The synthetic constructs were then ligated into the pPbHiT vector using the BbsI and PstI cloning sites. This places gRNA expression under the PbU6 promoter of the pPbHiT vector, and for tagging vectors the HR1 (corresponds to the 3’ end of the coding sequence) in-frame with the 3x-cMyc tag followed by the hsp70 3’UTR. Ligations were transformed into XL Gold E. coli as above and colonies were screened to check the presence of the insert by colony PCR using PbU6prom_F and hsp70UTR_R primers, except for the pooled vectors which were screened by NGS. The final pPbHiT vectors were linearised using the AvrII restriction enzyme prior to transfection.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6